Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 40.0B | 36.2B | 33.3B | 28.9B |
Cost of revenue | 7.4B | 6.9B | 6.4B | 5.3B |
Gross profit | 32.6B | 29.3B | 26.8B | 23.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 883.8M | 884.3M | 1.0B | 722.8M |
Other operating expenses | 976.3M | 819.8M | 683.0M | 390.5M |
Operating income | 19.1B | 18.0B | 14.2B | 15.0B |
Non operating interest income | ||||
Income | 876.9M | 1.3B | 1.1B | 899.8M |
Expense | 13.3B | 10.9B | 9.8B | 8.3B |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 10.9B | 6.6B | 9.0B |
Tax provision | -14.3B | 1.3B | 1.6B | 78.6M |
Net income | 16.2B | 9.6B | 5.1B | 8.9B |
Basic EPS | — | 10.2 | 5.3 | 9.4 |
Diluted EPS | — | 10.2 | 5.3 | 9.4 |
Basic average shares | — | 947.9M | 947.9M | 947.9M |
Diluted average shares | — | 947.9M | 947.9M | 947.9M |
EBITDA | 32.9B | 30.3B | 27.5B | 25.1B |
Net income from continuing op. | 775.2M | 10.0B | 5.8B | 8.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |